Downregulation of SERPINB13 expression in head and neck squamous cell carcinomas associates with poor clinical outcome

Department of Pathology, University Medical Centre Utrecht, Utrecht, The Netherlands.
International Journal of Cancer (Impact Factor: 5.09). 10/2009; 125(7):1542-50. DOI: 10.1002/ijc.24507
Source: PubMed


Tumorigenesis of head and neck squamous cell carcinomas (HNSCC) is associated with various genetic changes such as loss of heterozygosity (LOH) on human chromosome 18q21. This chromosomal region maps a gene cluster coding for a family of intracellular serine protease inhibitors (serpins), including SERPINB13. As SERPINB13 expression in HNSCC has recently been shown to be downregulated both at the mRNA and protein levels, here we investigated if such a low SERPINB13 expression is associated with histopathological and clinical parameters of HNSCC tumors and patient survival. By generating specific antibodies followed by immunohistochemistry on a well-defined cohort of 99 HNSCC of the oral cavity and oropharynx, SERPINB13 expression was found to be partially or totally downregulated in 75% of the HNSCC as compared with endogenous expression in non-neoplastic epithelial cells. Downregulation of SERPINB13 protein expression in HNSCC was significantly associated with the presence of LOH at the SERPINB13 gene in the tumors (p = 0.006), a poor differentiation grade of the tumors (p = 0.001), the presence of a lymph node metastasis (p = 0.012), and a decreased disease-free (p = 0.033) as well as overall (p = 0.018) survival of the patients. This is the first report demonstrating that downregulation of SERPINB13 protein expression in HNSCC is positively associated with poor clinical outcome. Therefore, SERPINB13 seems to act as an important protease inhibitor involved in the progression of HNSCC.

Download full-text


Available from: Marcel G.J. Tilanus, Mar 25, 2015
  • Source
    • "Also, extracellular presence of headpin reduce invasion, migration, and tube formation of endothelial cells, and when headpin is located at nucleus, it is able to regulate the transcription of mediators of cell proliferation [166]. The down-regulation of headpin gene by means of hypermethylation is linked with the development, aggressiveness and poor clinical outcome of oral, head and neck squamous cell carcinomas [167] [168]. Kallistatin or kallikrein-binding protein (KBP) is a serpin firstly discovered as an inhibitor of the kininogenase and amidolytic activities of tissue kallikrein in vitro with [169]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Protease inhibitors (PIs) encompass a large group of proteins that regulate the hydrolytic activity of proteolytic enzymes and play important physiological roles in all the living organisms. The protease/PI balance is necessary for cellular homeostasis, though, when such balance is broken, pathological conditions like cancer development are induced. The study of PIs as anti-cancer agents has been an important subject of research since more than three decades ago. There are a variety of mechanisms by which PIs perform their effects which depend on two main aspects: the nature, structure and functions of PI and, the interaction with a complex microenvironment that differs, even between cancers originated on the same source. There are many promissory cases, as well as, failures and paradoxical examples of PIs in the treatment of cancer which must be taken into consideration to propouse PI as possible part of the pharmaceutilcal strategies against cancer. In the following chapter the recent knowledge regarding signaling pathways involved in the anti-cancer effect of different classes of PIs, as well as their main features and the current perspectives in regard with their application as anti-cancer drugs will be discussed.
    New Approaches in the Treatment of Cancer, First edited by Ma. Del Carmen Mejia Vazquez (UNAM, Samuel Navarro, 01/2010: chapter V: pages 91-124; Nova Science Publishers, Inc.., ISBN: 978-1-61728-304-8
  • [Show abstract] [Hide abstract]
    ABSTRACT: Epithelial ovarian cancer is the most lethal gynecologic cancer with a 5 years survival rate of 30-40% in patients diagnosed with high-grade invasive disease (TOV). This is in stark contrast to the 95% 5 years survival rate in ovarian cancer patients diagnosed with low malignant potential (LMP) disease. The progression from localized tumor to invasive metastasis involves matrix proteolysis. Protease inhibitors are thought to play a key role by limiting this process. Using the Affymetrix HG-U133A GeneChip array, we have studied all serine protease inhibitors and found several serpin family members that are differentially expressed between LMP and TOV serous tumors. SERPINA1 was selected for further study due to its high expression in the majority of LMP tumors and its low expression in TOV tumors; observations that were also validated by quantitative-PCR (Q-PCR). To study the effects of its over expression on different tumorigenic parameters, SERPINA1 was cloned in the pcDNA3.1+ plasmid which was subsequently used to derive stable clones from two invasive ovarian cancer cell lines, TOV-112D and TOV-1946. We found no effect of SERPINA1 over expression on tumor growth in SCID mice although cell migration and invasion were affected in in vitro assays. There was also no association between patient survival and SERPINA1 immunostaining, however, SERPINA1 localization was different in LMP (nuclear) and TOV (cytoplasmic) tumors. SERPINA1 remains an interesting candidate since protein homeostasis, regulated by proteases and their inhibitors, should be studied holistically in order to assess their full impact in tumor progression.
    Clinical and Experimental Metastasis 01/2010; 27(1):55-69. DOI:10.1007/s10585-009-9303-6 · 3.49 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Serpins (serine protease inhibitors) are known as a diverse family of protease inhibitors; however, various other biological activities including tumor suppression, have been recently reported for these molecules. To clarify whether members of the serpin family are involved in OSCC (oral squamous cell carcinoma), global gene screening using microarray analysis was performed with OSCC-derived cell lines. A trend toward diminished expression was shown for some SERPIN genes located on 11q12-q13.1 and 18q21. mRNA expression of SERPIN genes at these chromosome regions was therefore analyzed using real-time quantitative RT-PCR (qRT-PCR) in 55 OSCC samples and matched normal tissue. Statistically significant decreases in expression were found for SERPINB12 (P=0.001), SERPINB13 (P=0.001), SERPINB4 (P=0.042), SERPINB3 (P<0.001), SERPINB11 (P<0.001), SERPINB7 (P=0.021) and SERPINB2 (P=0.018). All of these genes are located on 18q21, the known location of the serpin gene cluster. The results strongly suggest that this chromosome region plays a crucial role in OSCC. Some serpin members in the region might be involved in tumor suppression, or there might be unidentified tumor suppressor genes within or near the chromosome region.
    Oncology Reports 07/2010; 24(1):241-9. DOI:10.3892/or-00000852 · 2.30 Impact Factor
Show more